Dalpiciclib (SHR-6390) is a highly selective, oral bioavailable inhibitor of CDK4/6 that is used against CDK4 (IC50=12.4 nM) and CDK6 (IC50=9.9 nM) is equivalent. SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibitin
Molecular Weight:
446.54
Purity:
>98%
CAS Number:
[1637781-04-4]
Formula:
C25H30N6O2
Target:
CDK
* VAT and and shipping costs not included. Errors and price changes excepted